Treatment of premature ejaculati Treatment of premature ejaculation with Flouxetine: An open label study
premature ejaculation with Flouxetine: An open label study
Abstract
ABSTRACT
Background:
Premature ejaculation (PE) is a common problem in the male sexual dysfunction. Behavioral therapy had been used for many years to treat PE. In recent years many studies have indicated the beneficial effects of medications in the management of PE.
Objective:
Using only medication for treatment of PE.
Methods:
In this open-label study 16 patients with PE attending my private clinic were treated with flouxtine 20 mg/ day in a single morning oral dose for one month.
Results:
The response was dramatic, as 31% of patients improved within the first week, and 75% of patients improved within the second week, while all the patients (100%). improved at one month.
Conclusion:
Flouxetine could be used for treatment of PE . Further studies are essential to prove whether patients get cured.
Key words:
Premature ejaculation, flouxetine, subjective improvement.
Copyright (c) 2017 Iraqi Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Share — copy and redistribute the material in any medium or format
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
NonCommercial — You may not use the material for commercial purposes.
-
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
